圆柱心脏缺陷:分子遗传学,基因组学研究和创新的叙述性审查
Sruthi Viswanathan1,2, Prachi Sandeep Oza1,2, Anikha Bellad1,2
1Institute of Bioinformatics, Bengaluru, Bangalore, Karnataka, India.
Omics : a journal of integrative biology
|July 10, 2024
概括
先天性心脏缺陷 (CHDs),特别是状心脏缺陷 (CTDs),是常见的出生异常. 本综述强调了最近在了解CTD遗传原因,诊断和管理方面的进展.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 发展生物学 发展生物学
背景情况:
- 先天性心脏缺陷 (CHD) 是最常见的出生缺陷,导致显著的新生儿死亡率,特别是在发展中国家.
- 干性心脏缺陷 (CTDs) 代表了大量的CHDs子集,其分子遗传学和基因组基础仍然需要阐明.
- 尽管在诊断和外科干预方面取得了进展,但对CTD病因学的全面理解仍然不完整.
研究的目的:
- 提供关于近期 (自2016年1月以来) 干性心脏缺陷 (CTDs) 的分子遗传学和基因组学的最新进展的综合性审查.
- 检查CTDs的遗传病因,流行,胚胎学,诊断和临床管理.
- 要突出副本数变异,单核酸变异和与CTD相关的行星健康研究.
主要方法:
- 从2016年1月起出版的科学文献的叙事综述.
- 对与CTD相关的遗传变异 (CNV,SNV) 的研究分析.
- 包含有关CTD的行星健康研究和大型队列研究.
主要成果:
- 最近的研究揭示了CTD复杂的遗传情景,确定了特定的副本数和单核酸变异.
- 行星健康倡议越来越多地关注大规模的CTD研究.
- 了解遗传基质的进步正在改善诊断准确性和预后评估.
结论:
- 对CTD分子遗传学和基因组学的更深入的理解对于改善诊断和患者的治疗结果至关重要.
- 根据遗传特征量身定制的精准医学干预措施对CTD管理具有前景.
- 持续的全球研究工作对于准确的预后和CTD复发风险评估至关重要.
相关概念视频
Genomics
35.6K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
35.6K
Animal Mitochondrial Genetics
7.8K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.8K
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
Mitral Regurgitation I: Introduction
1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Stenosis I: Introduction
1.8K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Cardiomyopathy I: Introduction and Classification
828
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
828


